Colrain Capital LLC increased its position in Cigna Group (NYSE:CI – Free Report) by 106.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,500 shares of the health services provider’s stock after acquiring an additional 11,600 shares during the period. Cigna Group comprises about 3.7% of Colrain Capital LLC’s investment portfolio, making the stock its 12th biggest holding. Colrain Capital LLC’s holdings in Cigna Group were worth $6,486,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. Harbor Capital Advisors Inc. increased its position in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the last quarter. Solstein Capital LLC bought a new stake in Cigna Group during the second quarter valued at approximately $29,000. Chilton Capital Management LLC purchased a new stake in Cigna Group during the second quarter valued at approximately $30,000. Princeton Global Asset Management LLC increased its holdings in Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after buying an additional 52 shares during the last quarter. Finally, Collier Financial bought a new position in Cigna Group in the third quarter worth approximately $34,000. Institutional investors own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on CI shares. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Guggenheim reissued a “buy” rating and set a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. The Goldman Sachs Group decreased their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Jefferies Financial Group lifted their price objective on Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $330.00.
Cigna Group Stock Performance
NYSE:CI opened at $291.35 on Tuesday. The stock has a 50-day moving average price of $277.40 and a 200 day moving average price of $283.75. The stock has a market capitalization of $77.83 billion, a P/E ratio of 13.14, a P/E/G ratio of 1.01 and a beta of 0.27. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74.
Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the previous year, the firm earned $6.64 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date is Thursday, March 5th. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is presently 27.23%.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
